October 14, 2009 – Endologix Inc., developer of minimally invasive treatments for aortic disorders, said yesterday it evaluated the patent infringement lawsuit filed against the company last week by Cook Medical and says the suit is without merit.
Endologix said it intends to vigorously defend its position. "We are pleased that our initial evaluation of these claims, which Cook Medical waited for years to assert, has already yielded support for numerous promising defenses," said John McDermott, Endologix president and CEO.
Endologix flagship product is the Powerlink System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA).
For more information: www.endologix.com